Immunomodulation as a treatment strategy for genital herpes: review of the evidence
- 13 January 2002
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 2 (4) , 443-451
- https://doi.org/10.1016/s1567-5769(01)00184-9
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot StudyThe Journal of Infectious Diseases, 2001
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000
- The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' CellsClinical Immunology, 2000
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Effect of a Novel Topical Immunomodulator, S-28463, on Keratinocyte Cytokine Gene Expression and ProductionJournal of Interferon & Cytokine Research, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Immunomodulating and antiviral activities of the imidazoquinoline S-28463Antiviral Research, 1995
- AciclovirDrugs, 1994
- Evaluation of Herpes Simplex Virus Vaccines in Animals: The Guinea Pig Vaginal ModelClinical Infectious Diseases, 1991
- Recurrences after Oral and Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1987